Medical device company AtriCure names a new president & CEO after posting its 3Q earnings, which came in below analysts' estimates.
AtriCure names Michael Carrel its new CEO
West Chester, Ohio-based device maker AtriCure (NSDQ:ATRC) named Michael Carrel as president, CEO and a member of the board of directors of the company, effective November 1.
Carrel will receive an annual base salary of $500,000, plus a $40,000 bonus and a year-end bonus of $62,500. He is also eligible for an annual performance bonus of up to 125% of his base salary, according to regulatory filings.
Carrel was previously president & CEO at Vital Images, which was acquired by Toshiba in 2011. Carrel held the role until 2012.
"Mike brings a solid track record of establishing strategic vision, expanding businesses internationally and driving revenue growth and subsequent profitability. We look forward to his leadership and contribution here at AtriCure," director Michael Hooven said during an earnings call with investors.
AtriCure also promoted Andrew Wade to principal accounting and financial officer.
Edwards Lifesciences CEO Michael Mussallem says the company now expects the FDA to approve its next-...
Reva Medical begins enrolling patients in Europe for a trial of its Fantom bioresorbable stent.
A subcommittee of the U.S. Senate's powerful Finance Committee holds a hearing on the medical device...
Zimmer Holdings and Biomet find a buyer for the knee and elbow assets they pledged to divest to...